Sysmex (OTCMKTS:SSMXY) Shares Gap Down Following Weak Earnings

Sysmex Corporation ADR (OTCMKTS:SSMXY)’s share price gapped down prior to trading on Wednesday following a dissappointing earnings announcement. The stock had previously closed at $13.55, but opened at $12.89. Sysmex shares last traded at $12.89, with a volume of 551 shares trading hands.

The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by ($0.01). The firm had revenue of $895.73 million for the quarter, compared to analysts’ expectations of $859.71 million. Sysmex had a return on equity of 8.01% and a net margin of 7.62%. Sysmex has set its FY 2026 guidance at 0.415-0.415 EPS.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Sysmex from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 18th. Two research analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Sysmex Stock Down 4.9%

The business has a 50 day moving average of $12.03 and a 200-day moving average of $10.05. The stock has a market cap of $7.84 billion, a PE ratio of 30.69 and a beta of 1.19. The company has a current ratio of 3.40, a quick ratio of 2.53 and a debt-to-equity ratio of 0.23.

About Sysmex

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic testing instruments, reagents and related services. Its products are used by hospitals, clinical laboratories and other healthcare providers to analyze patient samples and support medical diagnosis. The company is best known for its hematology testing systems and also offers products for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory information systems and support services.